Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Methotrexate 2.5 mg Tablets

Active Ingredient:
methotrexate
Company:  
Cipla EU Ltd See contact details
ATC code: 
L04AX03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

DHPC Letter - Methotrexate

{healthcare_pro_orange} For Healthcare Professionals
To minimise the risk of overdose from patients incorrectly taking methotrexate daily instead of once weekly for autoimmune diseases
{pdf_link}

Methotrexate for autoimmune diseases: DHCP recommendations to reduce potentially fatal dosing errors

{healthcare_pro_orange} For Healthcare Professionals
The file guides you about the dosing precautions to be taken.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Cipla EU Ltd
Company image
Address
Dixcart House, Addlestone Road, Bourne Business Park, Addlestone,, KT15 2LE, UK
WWW
http://www.cipla.com
Telephone
+44 (0)1932 264688
Medical Information Direct Line
0800 0472144
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)207 399 4883
Stock Availability
[email protected]